August 21, 2019
Rose
The influential panel of experts says that women with previous breast, ovarian, fallopian-tube or abdominal cancer diagnoses who have completed treatment should be assessed for mutations of the BRCA1 and BRCA2 genes, as should women with ancestry more predisposed to those mutations.
from Kaiser Health News https://ift.tt/2HiSyfV
August 21, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Forty Years After First IVF Baby, Ethicists Are Still Fielding Panic Over Humans ‘Playing God’ With Children- ‘We Would Never Tolerate This In Other Areas Of Public Health’: Spiking Suicide Rates An Indictment Of Mental Health System
- Long, Unusually Intense Flu Season Was Deadliest For Kids In Nearly A Decade
- Beer Giant Pulls Funding Pledge For NIH Study Following Controversy Over Alcohol Industry’s Involvement
- A Gift For Democrats? Moderate Republicans Cringe Over Trump Administration’s Health Law Decision
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment